The Senate has raised alarm on the alleged
circulation of 42 anti-malaria drugs that
have been banned in Europe but are being
administered and sold to Nigerians in some
hospitals and pharmacies. During plenary
yesterday, the senate ordered its committee
on Health (Secondary and Tertiary), led by
Senator Olarewaju Tejuoso, to urgently carry
out an indepth investigation into the
allegation and report back for further action.
The Senate resolution came after a motion
by Senator Theodore Orji, was read on the
floor of the house.
Orji in his motion said “The Senate notes
that recently the European Union banned
the sale and consumption of 42 Anti-Malaria
Drugs in all countries within the European
Union. It notes that the 42 Anti-Malaria
Drugs are:
Alaxin 60mg tablet (dihydroartémisinine)
B/8;
Alaxin oral suspension
(dihydroartémisinine) FL/80ml;
Amodiaquine 200mg compressed B/1000;
Amodiaquine 200mg compressed B/1000;
Arinate 100mg tablet (artésunate) B/6;
Arinate 50mg tablet (artésunate) B/6;
Arsumax 50mg tablet (artésunate) B/12;
Artemax 60mg tablet (dihydroartémisinine)
B/8;
Artémédine 40mg capsule (artemether)
B/12;
Artémédine 50mg tablet (artemether) B/12;
Artenam 50mg tablet (artemether) B/14
Artenam 60mg tablet (artemether) B/8;
Artésiane 300mg child powder oral
suspension (artemether) FL/38g;
Artésunate 100mg compressed B/120;
Artésunate 50mg tablet B/120;
Artexin 60mg tablet (dihydroartémisinine)
B/8;
Camoquin 200mg tablet (amodiaquine) B/9;
Camoquin 200mg tablet (amodiaquine) B/25
blisters;
Camoquin 200mg tablet (amodiaquine) B/55
blisters;
Camoquin 200mg tablet (amodiquine) B/24;
Camoquin 600 mg tablet (amodiaquine) B/3;
Camoquin oral suspension 50mg/ 5ml
(amodiaquine) FL/60ml;
Cotecxin oral suspension
(dihydroartémisinine) FL/80ml;
Cotecxin 60mg tablet (dihydroartémisinine)
B/8;
Daraprim tablet (pyriméthamine) B/30;
and Falcinil 50mg tablet (artésunate) B/12.
